Novartis Pharma AG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Lichtstrasse 35, Basel, 4056, Switzerland (CHE)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3002807772 · DUNS 482347168
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-12-18
- VAIDrug Quality Assurance2022-08-30
- NAIDrug Quality Assurance2019-07-12
- VAIDrug Quality Assurance2017-07-06
- NAIDrug Quality Assurance2015-01-14
- NAIDrug Quality Assurance2013-12-05
- VAIDrug Quality Assurance2012-07-26
- NAIDrug Quality Assurance2012-07-18
- VAIDrug Quality Assurance2008-11-21
- VAIBioresearch Monitoring2008-11-06
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- deferoxamine mesylateMitem Pharma
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.